Last reviewed · How we verify

Testosterone Product — Competitive Intelligence Brief

Testosterone Product (Testosterone Product) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Androgen replacement therapy. Area: Endocrinology.

marketed Androgen replacement therapy Androgen receptor Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Testosterone Product (Testosterone Product) — Bayer. Testosterone replaces or supplements endogenous testosterone to restore normal androgen levels in hypogonadal patients.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Testosterone Product TARGET Testosterone Product Bayer marketed Androgen replacement therapy Androgen receptor
Talazoparib with enzalutamide talazoparib-with-enzalutamide Pfizer marketed PARP inhibitor and androgen receptor inhibitor PARP enzymes and androgen receptor Not yet launched
Winlevi CLASCOTERONE Sun Pharma marketed Androgen Receptor Inhibitor [EPC] Androgen receptor 2020-01-01
Nubeqa darolutamide Bayer marketed androgen receptor (AR) 2019-01-01
APALUTAMIDE APALUTAMIDE marketed Androgen Receptor (AR) 2018-01-01
Erleada apalutamide Johnson & Johnson marketed Androgen receptor 2018-01-01
Aveed TESTOSTERONE UNDECANOATE Marius marketed Androgen Androgen receptor 2014-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Androgen replacement therapy class)

  1. Clarus Therapeutics, Inc. · 2 drugs in this class
  2. Acerus Pharmaceuticals Corporation · 1 drug in this class
  3. Acrux DDS Pty Ltd · 1 drug in this class
  4. Alliance for Clinical Trials in Oncology · 1 drug in this class
  5. Bayer · 1 drug in this class
  6. Beersheva Mental Health Center · 1 drug in this class
  7. Imperial College Healthcare NHS Trust · 1 drug in this class
  8. Laboratoires Besins International · 1 drug in this class
  9. Lipocine Inc. · 1 drug in this class
  10. Memorial Sloan Kettering Cancer Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Testosterone Product — Competitive Intelligence Brief. https://druglandscape.com/ci/testosterone-product. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: